Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 12/20 | 0.53 |
| ▸ | PTGER3 | P43115 | 7/20 | 0.53 |
| ▸ | PTGER2 | P43116 | 6/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9150781 | 0.99 | PTGER4 (0.52) | PTGER4PTGER3PTGER2MEN1KMT2A | |
| SCHEMBL9151785 | 0.99 | PTGER4 (0.52) | PTGER4PTGER3PTGER2MEN1KMT2A | |
| SCHEMBL9152671 | 0.99 | PTGER4 (0.52) | PTGER4PTGER3PTGER2MEN1KMT2A | |
| SCHEMBL9148239 | 0.99 | PTGER4 (0.52) | PTGER4PTGER3PTGER2MEN1KMT2A | |
| SCHEMBL9154781 | 0.99 | PTGER4 (0.52) | PTGER4PTGER3PTGER2MEN1KMT2A | |
| SCHEMBL9148875 | 0.99 | PTGER4 (0.52) | PTGER4PTGER3PTGER2MEN1KMT2A | |
| SCHEMBL9150836 | 0.99 | PTGER4 (0.52) | PTGER4PTGER3PTGER2MEN1KMT2A | |
| SCHEMBL9151773 | 0.99 | PTGER4 (0.52) | PTGER4PTGER3PTGER2MEN1KMT2A | |
| SCHEMBL9152845 | 0.96 | PTGER4 (0.51) | PTGER4PTGER3PTGER2MEN1KMT2A | |
| SCHEMBL9152263 | 0.86 | MEN1 (0.52) | PTGER4PTGER3PTGER2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5472946-A | Topical administration of lincomycin, clindamycin, erthromycin and iododeoxyuridine on skin or mucuous membranes | DISCOVERY THERAPEUTICS, INC. | 1995-12-05 | — | — | US | disclosed |
| US-5470848-A | Penetration enhancers for transdermal delivery of systemic agents | DISCOVERY THERAPEUTICS, INC. | 1995-11-28 | — | — | US | disclosed |
| US-5444075-A | Penetration enhancers for transdermal delivery of systemic agents | MINASKANIAN GEVORK (US) | 1995-08-22 | — | — | US | disclosed |
| US-5234959-A | Omega-dialkylaminoalkanoic acids; drug delivery directly to the bloodstream | WHITBY RESEARCH, INC. (US) | 1993-08-10 | — | — | US | disclosed |
| US-5118676-A | Administering carboxylic derivatives as enhancer with systemically active agents | WHITBY RESEARCH, INC. (US) | 1992-06-02 | — | — | US | disclosed |
| US-5118692-A | Penetration enhances for transdermal delivery of systemic agents | WHITBY RESEARCH, INC. (US) | 1992-06-02 | — | — | US | disclosed |
| US-4996199-A | Penetration enhancers for transdermal delivery of systemic agents | WHITBY RESEARCH, INC. (US) | 1991-02-26 | — | — | US | disclosed |